Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Font Down Font Up

 
Court Rejects IBM's Appeal On Its Former M&A Chief's Appointment In Dell - Update
10/24/2009 4:27 PM  ET

RELATED NEWS
Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
IBM, Brown University Unveil Multimillion-Dollar Supercomputer - Quick Facts
IMPAQT Joins With IBM To Offer Unique Benefit To 100K IBM PartnerWorld Companies
IBM Inks 3-Yr Strategic Transformation Services Agreement With UK Driver And Vehicle Licensing Agency - Quick Facts
IBM Scientists Reinvent Medical Diagnostic Testing - Quick Facts
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Saturday, the U.S. Court of Appeals for the Second Circuit, has rejected International Business Machines Corp.'s (IBM: News ) appeal to impede the company's former merger and acquisition head, David Johnson from carry out his duties in Dell Inc. (DELL: News ).

In an appeal filed by IBM, the company has requested the court that David Johnson signed one year non-competition agreement during his appointment in the company. However, he violated the agreement by joining the company's arch rival Dell, after resigning from IBM.

It is said that Johnson has signed purposely in a wrong box on the agreement, and thus IBM's argument is invalid.

However, the court rejected IBM's claim by stating, "IBM failed to make sufficient showings that it had a likelihood of success on the merits or that a balance of the hardships tipped decidedly in its favor."
And finally, the court concluded that all of all of IBM's arguments are without merit. Accordingly, the June 26, 2009 order of the district court is affirmed.

Currently, in Dell, Dave Johnson serves as senior vice president, corporate strategy. In his role, he works with Michael Dell on the development of short- and long-term strategy, and also with leaders of the company's four international business units on their respective growth strategies.

IBM closed Friday's regular trading session at $120.36, down $2.33 or 1.90% on a volume of 6.8 million shares.\

To receive FREE breaking news email alerts for International Business Machines Corp and others in your portfolio


by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

     
  Trading Center
 

More Breaking News-US

126  FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
125  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
124  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
123  CF Nominees Enter Terra's Board - Update
122  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
121  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
120  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
119  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
118  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
117  Covidien's Pain Drug NDA Review Extended By FDA - Update
116  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
115  Cloud Peak Energy Prices IPO At $15/shr - Update
114  Met-Pro Q3 Profit Plunges - Update
113  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
112  Pfizer Granted FDA Approval For Intravenous Formulation Of Revatio - Update
  

 

Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS